Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T04:00:32.892Z Has data issue: false hasContentIssue false

Patterns of middle-ear cholesteatoma and implications for surgical approach

Published online by Cambridge University Press:  23 January 2020

Y Yu
Affiliation:
Department of Otolaryngology, Changi General Hospital, Singapore
J See
Affiliation:
Department of Otolaryngology, Changi General Hospital, Singapore
J H Ng
Affiliation:
Department of Otolaryngology, Changi General Hospital, Singapore
D Low
Affiliation:
Department of Otolaryngology, Changi General Hospital, Singapore
T Y Tan
Affiliation:
Department of Diagnostic Radiology, Changi General Hospital, Singapore
H W Yuen*
Affiliation:
Department of Otolaryngology, Changi General Hospital, Singapore
*
Author for correspondence: Dr Heng Wai Yuen, Department of Otolaryngology, Changi General Hospital, 2 Simei Street 3, Singapore529889 E-mail: [email protected] Fax: +65 6788 0933
Rights & Permissions [Opens in a new window]

Abstract

Objectives

Understanding the pattern of middle-ear cholesteatoma becomes pertinent with the rise of endoscopic surgery as surgeons decide on the optimal approach to visualise and extirpate disease. With modifications to the Telmesani attic–tympanum–mastoid staging system, this study aimed to evaluate the commonest patterns of middle-ear cholesteatoma and their implications for surgical approach.

Methods

A retrospective study was conducted in a single tertiary institution in Singapore. All patients undergoing cholesteatoma surgery between January 2012 and June 2015 were included. Staging of cholesteatoma was based on clinical assessment corroborated by radiological findings.

Results

Out of the 55 ears included, 98.2 per cent had cholesteatoma involving the attic. The disease extended into the mastoid antrum and beyond in 43 cases (78.2 per cent). The facial recess and/or sinus tympanum was affected in 26 cases (47.3 per cent).

Conclusion

The majority of cholesteatoma cases present with extensive attic disease and significant mastoid involvement. In these cases, endoscopes may be best suited to adjunctive rather than exclusive use in surgery.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited, 2020

Introduction

Understanding the pattern of involvement of middle-ear cholesteatoma is important for achieving the primary goal of cholesteatoma surgery; namely, the complete eradication of disease, and creation of a safe and dry ear. JacklerReference Jackler1 was the first to describe the typical routes of cholesteatoma growth based on anatomical boundaries and middle-ear space compartments. Tos and LauReference Tos and Lau2 demonstrated considerable differences in the extent of cholesteatoma depending on its site of origin.

In recent years, with the rise of endoscopic ear surgery, this subject has become even more pertinent. Surgeons have to decide between the use of a microscopic, endoscopic or combined approach to visualise and extirpate middle-ear cholesteatoma. The current literature suggests that the conventional microscopic approach is well suited to areas such as the mastoid,Reference Bennett, Zhang, Labadie and Noble3Reference Nogueira and Cohen5 whereas endoscopy allows for better visualisation of areas such as the sinus tympani and facial recess,Reference Bennett, Zhang, Labadie and Noble3 reducing the rate of residual disease.Reference Ayache, Tramier and Strunski6Reference Presutti, Gioacchini, Alicandri-Ciufelli, Villari and Marchioni8 A combined approach may achieve the best of both worlds, but may not always be necessary when there is limited disease. The choice of surgical approach should be individualised depending on the involvement and extent of middle-ear cholesteatoma in different patients.

Previous studies, such as those by Jackler,Reference Jackler1 Tos and Lau,Reference Tos and Lau2 Maresh et al.Reference Maresh, Martins, Victor and Selesnick9 and Rosito et al.,Reference Rosito, Netto, Teixeira and da Costa10 have investigated the pattern of cholesteatoma involvement and/or have classified growth patterns. However, these studies did not separately grade the extent of attic, tympanum, mastoid, or sinus tympani or facial recess involvement. This information is critical in selecting between microscopic, endoscopic and combined approaches for surgical extirpation.

With modifications to the attic–tympanum–mastoid (‘ATM’) classification system proposed by Telmesani et al.,Reference Telmesani, Sayed and Bahrani11 this study aimed to evaluate the commonest patterns of middle-ear cholesteatoma involvement. This knowledge will aid in the selection of the optimal surgical approach for surgical extirpation of cholesteatomas.

Materials and methods

All patients undergoing surgery for cholesteatoma at a single tertiary institution between January 2012 and June 2015 were included in this study, after obtaining approval from the SingHealth Institutional Review Board. Medical records were reviewed retrospectively, and data including patient demographics, clinical history, examination findings, surgical records and computed tomography (CT) temporal bone scan findings were collected.

All patients scheduled to undergo cholesteatoma surgery routinely have a CT temporal bone scan performed pre-operatively. This is a high-resolution, multi-detector CT temporal bone scan, at 0.625 mm collimation with 50 per cent overlap, reconstructed at 0.3 mm increments in the axial plane. Images were read and reported by a radiologist with a subspecialty in head and neck imaging. Intra-operative microscopic evaluation of the extent of cholesteatoma and presence of complications was conducted by the senior author, who was the primary surgeon performing the operation in all cases.

Where the disease, especially in the sinus tympani, was assessed to be beyond the field of view with the microscope despite maximal safe surgical exposure, the endoscope was used to inspect the middle-ear cavity, and, when necessary, disease was removed endoscopically.

Staging of cholesteatoma was determined clinically and corroborated with the radiological findings based primarily on the grading system proposed by Telmesani et al.Reference Telmesani, Sayed and Bahrani11 Specifically, cholesteatoma sites were divided into attic (A), tympanic cavity (T) and mastoid (M), with specific identification of the facial recess and/or sinus tympani extension (S). Each site was given a grade of 0–3 reflecting progressive involvement (Table 1).

Table 1. Staging of cholesteatoma

Complications to be considered in grading include: ossicular erosion (‘OE’), defined as the erosion of one or more ossicles (malleus, incus or stapes) in the middle ear, with ossicular discontinuity; dehiscence of tegmen tympani (‘DTT’), defined as complete bony erosion that allows communication between the middle ear and the cranial fossa; lateral semicircular canal fistula (‘LSCF’), defined as complete erosion of the bony labyrinth, exposing the inner membrane of the lateral semicircular canal; round or oval window involvement (‘WI’), defined as disease involvement immediately adjacent to the windows; and automastoidectomy (‘AM’). *According to the Telmesani attic–tympanum–mastoid staging system. The abbreviation ‘S’ in grading denotes facial recess and/or sinus tympani involvement.

Telmesani and colleagues’ classification system,Reference Telmesani, Sayed and Bahrani11 proposed in 2009, was meant to be used on the pre-operative CT temporal bone scans of patients scheduled for cholesteatoma surgery. Hence, variables such as the presence of ossicular erosion and inner-ear involvement were not included in the classification system, as the CT temporal bone scans at that time did not afford a high enough resolution (2 mm cuts) to determine this with sufficient accuracy. As such, for the purpose of the current study, we added more variables to Telmesani's classification system, so as to more thoroughly define the extent of cholesteatoma. In addition to the variables in Telmesani's classification system, the presence of an automastoidectomy cavity, ossicular erosion, tegmen tympani dehiscence, a lateral semicircular canal fistula, and round or oval window involvement were also noted. This is summarised in Table 1.

Cholesteatoma surgery aims to produce a safe cavity for easy surveillance. Two main types of surgery were performed during this period: modified radical mastoidectomy with meatoplasty, and atticotomy or atticoantrostomy with meatoplasty.

The patients were followed up regularly for a period of at least one year. Any suspicion of residual disease was recorded. Residual cholesteatoma is defined as a collection of squamous epithelium found in the middle ear or mastoid cavity likely due to incomplete local resection of pathological squamous epithelium at the time of surgery.Reference Rutkowska, Ozgirgin and Olszewska12 Recurrent cholesteatoma is defined as development of a new cholesteatoma in a newly formed retraction pocket.Reference Rutkowska, Ozgirgin and Olszewska12

Results

A total of 53 patients (55 ears) underwent surgery for cholesteatoma. The diagnosis of cholesteatoma was made clinically, supported by radiological findings on CT temporal bone scans, and further confirmed by intra-operative findings and histology.

Out of the 53 patients studied, 10 had bilateral middle-ear cholesteatoma; however, only 2 patients with bilateral disease had both ears included in the study, as both ears were operated on at the study institution within the 3.5-year study duration. There were 31 left ears and 24 right ears.

Of the ears included, 31 belonged to males (56.4 per cent) and 24 to females (43.6 per cent). Patient ages ranged from 15 to 90 years, with a mean (standard deviation) of 45.8 (18.4) years. The patients presented with otorrhoea (67.9 per cent), hearing loss (41.5 per cent), otalgia (26.4 per cent), vertigo (7.5 per cent) and tinnitus (3.8 per cent).

As shown in Table 2, the majority of cases had cholesteatoma involving the attic (98.2 per cent). The cholesteatoma extended to the facial recess and/or sinus tympanum in 26 cases (47.3 per cent). The disease extended into the mastoid antrum and beyond in 43 cases (78.9 per cent).

Table 2. Summary of results

* Total of 55 ears (53 patients)

Ten cases (18.2 per cent) had an automastoidectomy cavity. In 46 cases (83.6 per cent), the ossicular chain demonstrated signs of erosion. Dehiscence of the tegmen tympani was observed in 11 cases (20 per cent). There were eight cases (14.5 per cent) with lateral semicircular canal fistula. Three cases (5.5 per cent) had disease involvement of the round and/or oval windows. Only in one case was surgery conducted with the aid of an endoscope for visualisation of the cholesteatoma sac, which was extending into the sinus tympani.

One case (1.8 per cent) had a significant complication, with bleeding from the meatoplasty wound. Out of the 55 cases, 43 (78.2 per cent) were on regular follow up for more than one year. The mean duration of follow up was 42.2 months (range, 0–82 months). Three patients were only followed up for less than one month, as they did not reside in Singapore. Only one patient had recurrent disease, which was detected 22 months after initial surgery; this required revision surgery for squames medial to a mastoid cavity scar band that was obliterating the antrum and sinodural angle. None of the other patients had residual or recurrent disease at the last follow-up visit.

Discussion

Grading the extent of cholesteatoma serves to provide a common criterion for the comparison of surgical outcomes and prognosis among surgeons. It is also an important decision-making tool for determining the best surgical approach for extirpation of disease, especially given the rise of endoscopic ear surgery.

Although various studies have classified middle-ear cholesteatomas, none has individually graded the extent of involvement in the attic, tympanum and mastoid. Rosito et al.Reference Rosito, Netto, Teixeira and da Costa10 studied growth patterns of cholesteatoma, and found that the majority of cholesteatomas originated in the posterior epitympanum (34.3 per cent) or posterior mesotympanum (33.8 per cent). A smaller number involved: both the epitympanum and mesotympanum (13.8 per cent), the attic only (1.9 per cent), or were undetermined (16.2 per cent) because of extensive disease involvement. Another study, by Black and Gutteridge,Reference Black and Gutteridge13 yielded similar results to those of Rosito et al.Reference Rosito, Netto, Teixeira and da Costa10 However, neither study graded the extent of middle ear involvement, and only classified cholesteatomas according to region of origin.

Similar to our study, Saleh and MillsReference Saleh and Mills14 classified cholesteatomas based on extent of involvement. The study staged cholesteatomas based on the region of origin (attic or pars tensa) as well as number of contiguous areas involved. However, the study did not individually grade the extent of involvement of each area, nor did it quantify the number of cases in which the sinus tympani was involved. This information is relevant as more extensive mastoid involvement may render the endoscopic approach inadequate,Reference Glikson, Yousovich, Mansour, Wolf, Migirov and Shapira7,Reference Yung15,Reference Tarabichi16 and presence of disease in the sinus tympani may make the use of endoscopes helpful.

One of the main strengths of endoscopic ear surgery is the improved visualisation of, and ability to remove disease from, hidden areas in the middle ear, especially the sinus tympani, facial recess and anterior epitympanum.Reference Bennett, Zhang, Labadie and Noble3 The use of an endoscope and its round-the-corner vision reduces the incidence of residual cholesteatoma by improving visualisation of remnant disease, especially in the sinus tympani, which could otherwise be overlooked when using the microscope alone.Reference Ayache, Tramier and Strunski6,Reference Yung15,Reference Badr-el-Dine17Reference EL-Meselaty, Badr-El-Dine, Mandour, Mourad and Darweesh19 Our study found that cholesteatoma was present in the facial recess and/or sinus tympani in 47.3 per cent of cases. This is similar to the findings of Yung,Reference Yung15 who found that 41.1 per cent of patients had cholesteatoma in the sinus tympani. Hence, the use of endoscopes as an adjunct to the operating microscope in cholesteatoma removal could potentially benefit a substantial number of patients.

Further to that, some authors have advocated the exclusive use of endoscopes in cholesteatoma surgery, even in some cases with disease involving the mastoid.Reference Marchioni, Villari, Alicandri-Ciufelli, Piccinini and Presutti20 However, most authors suggest careful selection of patients for the endoscopic-only approach. TarabichiReference Tarabichi16 first described endoscopic accessibility for disease that does not extend beyond the level of the lateral semicircular canal posteriorly. Other authors generally exclude cases with mastoid extension of disease from an exclusively endoscopic approach.Reference Glikson, Yousovich, Mansour, Wolf, Migirov and Shapira7,Reference Magliulo and Iannella21

Marchioni et al.Reference Marchioni, Soloperto, Rubini, Villari, Genovese and Artioli22 used the Telmesani classification for cholesteatoma staging in a paediatric population. They found a significant correlation between the A2 and A3 stages (more extensive attic disease) and recurrence, with the A3 stage resulting in a statistically significant higher risk than A1 and A2 stages for antral and mastoid recurrence. However, Marchioni and colleagues’ paper did not show a statistically significant difference between the exclusively transcanal endoscopic approach and the microscopic canal wall up approach.

Migirov et al.Reference Migirov, Shapira, Horowitz and Wolf23 and Glikson et al.Reference Glikson, Yousovich, Mansour, Wolf, Migirov and Shapira7 performed an exclusively transcanal endoscopic approach on patients with cholesteatoma not extending beyond the lateral semicircular canal. Migirov and colleagues’ study showed no residual disease in all 18 patients who were followed up for more than one year. Glikson and colleagues’ study showed overall residual and recurrence rates of 10 per cent and 8.3 per cent, respectively, for a patient cohort of 60 patients with a mean follow-up duration of 35 months. Magliulo and IannellaReference Magliulo and Iannella21 compared primary exclusive endoscopic surgery and a conventional approach in a group of patients with cholesteatoma limited to the attic, and found no difference in surgical outcomes. The good outcomes could be possibly attributed to the exclusion of all patients with mesotympanic or mastoid extension of disease. This highlights the importance of careful selection of patients with limited disease for the success of an endoscopic-only approach.

The patients in our study presented with middle-ear cholesteatoma that was extensive: 85.4 per cent of cases had disease that extended beyond the posterior attic (A1/A3), 43.6 per cent had disease that extended beyond the posterior mesotympanum (T1/T3), and 58.2 per cent had disease that extended beyond the mastoid antrum (M2/M3). As discussed above, particularly when cholesteatoma extends beyond the antrum into the mastoid cavity, there is poor visualisation with a transcanal endoscopic approach, and a microscopic or combined approach is usually more ideal.Reference Glikson, Yousovich, Mansour, Wolf, Migirov and Shapira7 Moreover, there is limited evidence on the exclusive use of an endoscopic approach in cholesteatoma cases with complications, other than ossicular reconstruction cases. Preliminary results for ossicular reconstruction with an exclusively transcanal endoscopic approach are promising,Reference Tarabichi16,Reference Migirov, Shapira, Horowitz and Wolf23 but more studies comparing the microscopic and endoscopic approaches are needed. Fifteen cases with disease that did not extend beyond the antrum also did not have complications of tegmen dehiscence and/or lateral semicircular canal fistula; thus, only 27.3 per cent of cases could have potentially benefitted from a transcanal endoscopic approach.

Our population has relatively good access to healthcare, with a doctor-to-population ratio of 1:420,24 and our centre provides both secondary and tertiary healthcare. Nonetheless, most patients in our study have advanced cholesteatomas, and therefore may not be suitable candidates for surgery utilising an endoscopic-only approach. We did not use an endoscopic-only approach for any patient, and only in one case was an endoscope needed for better visualisation of the disease. For more limited cholesteatomas, we perform atticotomy, and may reconstruct the canal wall afterwards. Intact canal wall mastoidectomy was not performed because of the advanced disease presentation. In addition, our patient population tends to be resistant to second-look procedures, opting for definitive procedures instead. It is important to understand common cholesteatoma disease patterns in our patients as certain surgical approaches may increase cholesteatoma recurrence rates.

  • The pattern of middle-ear cholesteatoma affects the choice of surgical approach since the advent of endoscopic ear surgery

  • Using a modified Telmesani staging system, 55 ears with cholesteatoma were assessed; 98.2 per cent involved the attic

  • Cholesteatoma extended to the facial recess and/or sinus tympanum in 26 cases, and into the mastoid antrum and beyond in 43

  • Ten cases had an automastoidectomy cavity, 46 had ossicular chain erosion signs, 11 had tegmen tympani dehiscence

  • Eight cases had lateral semicircular canal fistula, and three had disease involvement of the round and/or oval windows

  • Most cholesteatomas present with extensive attic disease and mastoid involvement; endoscopes may be best suited to adjunctive rather than exclusive use in surgery

Although there have been a few proposed classifications of cholesteatoma, there is a lack of literature comparing surgical outcomes, likely because of fundamental disagreements within the international otology community regarding a common classification system.Reference Yung, Tono, Olszewska, Yamamoto, Sudhoff and Sakagami25 The Tos and LauReference Tos and Lau2 classification (1989) helped us understand the site of origin of cholesteatoma and its common paths of spread, but it is limited in clinical use as it is often difficult to determine the origin of disease in advanced disease cases.Reference Rosito, Netto, Teixeira and da Costa10 Saleh and MillsReference Saleh and Mills14 devised a staging system with the Tos classification as the basis, by categorising the extent of disease, ossicular damage and complications based on intra-operative findings. However, correlation with pre-operative CT findings was not performed. The attic–tympanum–mastoid system proposed by Telmesani et al.Reference Telmesani, Sayed and Bahrani11 and the tympanum–mastoid–complications (‘TMC’) system put forward by Belal et al.Reference Belal, Reda, Mehana and Belal26 both classified cholesteatoma based on disease extent, and demonstrated a high correlation between clinico-radiological findings and intra-operative findings. Our study mainly adopted the Telmesani classification system, with modifications, as it is simple and practical, involving separate evaluation of the different middle-ear parts.

To the best of our knowledge, this is the first study to evaluate the patterns of middle-ear cholesteatoma in an adult population using the existing Telmesani classification. Although retrospective in nature, a single surgeon evaluated all the patients’ disease, with findings corroborated by CT reports from a specialised head and neck radiologist. This study did not aim to compare the surgical outcomes of the endoscopic and microscopic approaches, and correlate the findings with different disease extent. Instead, our study highlights the importance of implementing a classification system for the evaluation of disease extent for future meaningful comparison of surgical outcomes.

Conclusion

Our study indicates that the majority of cholesteatoma patients present with extensive attic disease and disease significantly involving the mastoid cavity. In these cases, endoscopes may be best suited to adjunctive rather than exclusive use in cholesteatoma surgery. It is crucial to review the extent and pattern of cholesteatoma involvement in order to select the best approach for surgical extirpation, as using the endoscopic-only approach in extensive disease has been shown to increase recurrence rates. While the endoscopic wider field of view does afford better visualisation of the various recesses in the middle-ear cavity, it is important to be flexible, in order to capitalise and fully optimise the advantages both of endoscopic and microscopic approaches in cholesteatoma surgery.

Competing interests

None declared

Footnotes

Dr H W Yuen takes responsibility for the integrity of the content of the paper

References

Jackler, RK. The surgical anatomy of cholesteatoma. Otolaryngol Clin North Am 1989;22:883–96Google ScholarPubMed
Tos, M, Lau, T. Late results of surgery in different cholesteatoma types. ORL J Otorhinolaryngol Relat Spec 1989;51:3349CrossRefGoogle ScholarPubMed
Bennett, ML, Zhang, D, Labadie, RF, Noble, JH. Comparison of middle ear visualization with endoscopy and microscopy. Otol Neurotol 2016;37:362–6Google ScholarPubMed
Preyer, S. Endoscopic ear surgery – a complement to microscopic ear surgery. HNO 2017;65(suppl 1):2934CrossRefGoogle ScholarPubMed
Nogueira, JF, Cohen, MS. Combined endoscopic and microscopic approaches to cholesteatoma. Oper Tech Otolaryngol Head Neck Surg 2017;28:36–8CrossRefGoogle Scholar
Ayache, S, Tramier, B, Strunski, V. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected? Otol Neurotol 2008;29:1085–90CrossRefGoogle Scholar
Glikson, E, Yousovich, R, Mansour, J, Wolf, M, Migirov, L, Shapira, Y. Transcanal endoscopic ear surgery for middle ear cholesteatoma. Otol Neurotol 2017;38:e41–5CrossRefGoogle ScholarPubMed
Presutti, L, Gioacchini, FM, Alicandri-Ciufelli, M, Villari, D, Marchioni, D. Results of endoscopic middle ear surgery for cholesteatoma treatment: a systematic review. Acta Otorhinolaryngol Ital 2014;34:153–7Google ScholarPubMed
Maresh, A, Martins, OF, Victor, JD, Selesnick, SH. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth. Otol Neurotol 2011;32:1239–42CrossRefGoogle ScholarPubMed
Rosito, LS, Netto, LFS, Teixeira, AR, da Costa, SS. Classification of cholesteatoma according to growth patterns. JAMA Otolaryngol Head Neck Surg 2016;142:168–72CrossRefGoogle ScholarPubMed
Telmesani, L, Sayed, H, Bahrani, N. Proposed clinical classification of cholesteatoma. Egypt J Ear Nose Throat Allied Sci 2009;10:50–3Google Scholar
Rutkowska, J, Ozgirgin, N, Olszewska, E. Cholesteatoma definition and classification: a literature review. J Int Adv Otol 2017;13:266–71CrossRefGoogle ScholarPubMed
Black, B, Gutteridge, I. Acquired cholesteatoma: classification and outcomes. Otol Neurotol 2011;32:992–5CrossRefGoogle ScholarPubMed
Saleh, HA, Mills, RP. Classification and staging of cholesteatoma. Clin Otolaryngol Allied Sci 1999;24:355–9CrossRefGoogle ScholarPubMed
Yung, MW. The use of middle ear endoscopy: has residual cholesteatoma been eliminated? J Laryngol Otol 2001;115:958–61CrossRefGoogle ScholarPubMed
Tarabichi, M. Endoscopic management of limited attic cholesteatoma. Laryngoscope 2004;114:1157–62CrossRefGoogle ScholarPubMed
Badr-el-Dine, M. Value of ear endoscopy in cholesteatoma surgery. Otol Neurotol 2002;23:631–5CrossRefGoogle ScholarPubMed
Sajjadi, H. Endoscopic middle ear and mastoid surgery for cholesteatoma. Iran J Otorhinolaryngol 2013;25:6370Google ScholarPubMed
EL-Meselaty, K, Badr-El-Dine, M, Mandour, M, Mourad, M, Darweesh, R. Endoscope affects decision making in cholesteatoma surgery. Otolaryngol Head Neck Surg 2003;129:490–6CrossRefGoogle ScholarPubMed
Marchioni, D, Villari, D, Alicandri-Ciufelli, M, Piccinini, A, Presutti, L. Endoscopic open technique in patients with middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2011;268:1557–63CrossRefGoogle ScholarPubMed
Magliulo, G, Iannella, G. Endoscopic versus microscopic approach in attic cholesteatoma surgery. Am J Otolaryngol Head Neck Med Surg 2018;39:2530Google ScholarPubMed
Marchioni, D, Soloperto, D, Rubini, A, Villari, D, Genovese, E, Artioli, F et al. Endoscopic exclusive transcanal approach to the tympanic cavity cholesteatoma in pediatric patients: our experience. Int J Pediatr Otorhinolaryngol 2015;79:316–22CrossRefGoogle ScholarPubMed
Migirov, L, Shapira, Y, Horowitz, Z, Wolf, M. Exclusive endoscopic ear surgery for acquired cholesteatoma: preliminary results. Otol Neurotol 2011;32:433–6CrossRefGoogle ScholarPubMed
Ministry of Health, Singapore. Health Manpower. In: https://www.moh.gov.sg/resources-statistics/singapore-health-facts/health-manpower [16 March 2019]Google Scholar
Yung, M, Tono, T, Olszewska, E, Yamamoto, Y, Sudhoff, H, Sakagami, M et al. EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J Int Adv Otol 2017;13:18CrossRefGoogle ScholarPubMed
Belal, A, Reda, M, Mehana, A, Belal, Y. A new staging system for tympano-mastoid cholesteatoma. J Int Adv Otol 2012;8:63–8Google Scholar
Figure 0

Table 1. Staging of cholesteatoma

Figure 1

Table 2. Summary of results